TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,113,628 | -35.3% | 611,678 | +92.2% | 0.02% | -37.5% |
Q2 2023 | $7,905,827 | +2441.7% | 318,270 | +1438.9% | 0.02% | +2300.0% |
Q1 2023 | $311,042 | -88.0% | 20,681 | -95.3% | 0.00% | -90.0% |
Q3 2022 | $2,588,000 | +2231.5% | 437,200 | +2103.1% | 0.01% | +900.0% |
Q3 2019 | $111,000 | -98.2% | 19,845 | -97.2% | 0.00% | -96.9% |
Q2 2019 | $6,055,000 | -41.1% | 700,000 | -45.3% | 0.03% | -31.9% |
Q1 2019 | $10,282,000 | +19.9% | 1,278,900 | +111.8% | 0.05% | +30.6% |
Q1 2018 | $8,574,000 | – | 603,800 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |